2Brown - Elliott B A, Brown J M, Conville P S, et al. Clinical and laboratory features ofth~ Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev, 2006, 19 (2): 259.
3Matulionyte R, Rohner P, Uckay I, et al. Seeular trends of no- cardia infection over 15 years in a tertiary care hospital. J Clin Pathol, 2004, 57:807.
4Chlh- Cheng Lai, Wei- Iam Liu, Wen- Claien Ko, et al. Mul- ticenter study in Taiwan of the in vitro activities of nomonoxacin, tigecycline, doripenem, and other antimierobial agents against clin- ical isolates of various Nocardia species. Antimierob Agents Chemother, 2011, 55 (5): 2048.
